PDC calculation - ANSWER (# of unique days with supply / number of days in a period) x 100
Jak inhibitor - ANSWER Xeljanz (tofacitinib)
Cholesterol-elevating medication - ANSWER Actemra (toclizumab)
Shingles vaccine safe with TNF inhibitors - ANSWER Shingrix
Neutropenia risk - ANSWER Taltz (ixekizumab)
Psoriasis medication without tuberculosis screening - ANSWER Otezla (apremilast)
Standard starting dose for Taltz (ixekizumab) in psoriatic arthritis - ANSWER 160mg subcutaneously once,
followed by 80mg subcutaneously every 4 weeks
Medication recommendation for severe dermatitis in a 45 y/o patient - ANSWER Dupixent (dupilumab)
Starting dose for Stelara (ustekinumab) in psoriasis - ANSWER Inject 45 mg subcutaneously at weeks 0
and 4, followed by 45 mg every 12 weeks
Oral oncology medication without caution in hepatic impairment - ANSWER Ibrance (palbociclib)
Non-side effect of Zytiga (abiraterone acetate) - ANSWER Mucositis
Smoking effect on Tarceva (erlotinib) levels - ANSWER Smoking decreases Tarceva levels and the
medication will be less effective if he continues to smoke